Clinical Trial: Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07186452) titled 'Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors' on Sept. 09.

Brief Summary: The primary objective of this study is to evaluate the effect of itraconazole on the pharmacokinetics of HS-20093 in patients with advanced solid tumors.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: HS-20093

All participants will receive intravenous infusion of HS-20093 at a dose of 8 mg/kg every 3 weeks (Q3W), with each treatment cycle lasting 21 days.

DRUG: Itraconazole

Participants will then take itraconazole capsule...